Vargas C, Carrello J, Bressel M, Sidhom M, et al. SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial. Int J Radiat Oncol Biol Phys 2026;125:173-184.
PMID: 40578451